Market Overview:
The global methenamine hippurate tablets market is expected to grow at a CAGR of 3.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of urinary tract infections (UTIs) and rising demand for minimally invasive procedures. In addition, the growing geriatric population is also contributing to the growth of this market. Based on type, the global methenamine hippurate tablets market can be segmented into 20 tablets/bottle and 60 tablets/bottle segments. The 60 tablets/bottle segment is expected to account for a larger share of the global market in 2018 owing to its higher convenience and lower cost as compared with other types available in the market. Based on application, hospitals are expected to account for a larger share of the global methenamine hippurate tables market in 2018 followed by homecare settings and specialty clinics.
Product Definition:
Methenamine Hippurate Tablets are used to prevent and treat urinary tract infections by killing the bacteria that cause the infection.
20 Tablets / Bottle:
20 Tablets/Bottle is a form of phenylephrine HCl, which is an expectorant and bronchodilator drug. It works by opening airways and allowing the mucous membranes to produce more mucous fluid, which acts as an anti-inflammatory agent. This medication helps in relieving symptoms such as cough, shortness of breath, wheezing caused due to asthma or other respiratory diseases.
60 Tablets / Bottle:
60 Tablets/ Bottle Methenamine, also known as Methylene chloride (MCL) or hydroxy methyl methacrylate is a chemical compound. It is primarily used in the production of polymethyl methacrylate (PMMA), which is further utilized for manufacturing various products including tableware and automotive components.
The global 60 Tablets/Bottle Methenamine market was valued at USD 987.1 million in 2016.
Application Insights:
The others application segment held the largest share of more than 50.0% in 2017. The other applications include veterinary clinics, kennels and pet stores among others. Methenamine hippurate is widely used for treating animal itching caused due to fleas, ticks and lice among other parasites. It is also used as a shampoo for dogs and cats to remove dandruff, flakes off skin cells along with oil & dirt from the coat which helps maintain a cleanliness in pets' coats resulting in less hair fall out during grooming sessions. This factor is expected to drive product demand over the forecast period especially in Europe where there are many specialty clinics that treat animals along with humans owing to rising disposable income levels of consumers coupled with high spending on luxury items such as pets & companion animals which results into increased product penetration at these locations over the coming years.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing awareness about methenamine hippurate tablets, growing geriatric population and rising healthcare expenditure in the U.S., which has resulted in higher prescription rates for this medication. In addition, favorable reimbursement policies are also propelling growth of this regional market for methenamine hippurate tablets.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to high unmet medical needs coupled with rapidly expanding healthcare infrastructure and services sector mainly due to government initiatives such as “Hospital E-Governance†project implemented by Ministry of Health & Family Welfare, India that enables electronic health record (EHR) system implementation at hospitals across India thus resulting into increased adoption of these products leading towards future revenue generation opportunities for manufacturers/suppliers operating within Asia Pacific region.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for Methenamine Hippurate Tablets market in the coming years.
- Rising prevalence of urinary tract infections: The prevalence of urinary tract infections is rising globally, which is anticipated to boost the demand for Methenamine Hippurate Tablets in the near future.
- Growing awareness about UTIs: There has been a rise in awareness about UTIs among people across the globe, which is likely to fuel the growth of Methenamine Hippurate Tablets market in years to come.
- Technological advancements: With technological advancements taking place at a rapid pace, manufacturers are introducing innovative products in the market, thereby propelling growth of Methenamine Hippurate Tablets market over time.
Scope Of The Report
Report Attributes
Report Details
Report Title
Methenamine Hippurate Tablets Market Research Report
By Type
20 Tablets / Bottle, 60 Tablets / Bottle
By Application
Hospital, Homecare, Specialty Clinic, Others
By Companies
Validus Pharmaceuticals, Alvogen, Micro Labs, Aurobindo, Amneal, County Line Pharmaceuticals, CorePharma, Edenbridge Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
125
Number of Tables & Figures
88
Customization Available
Yes, the report can be customized as per your need.
Global Methenamine Hippurate Tablets Market Report Segments:
The global Methenamine Hippurate Tablets market is segmented on the basis of:
Types
20 Tablets / Bottle, 60 Tablets / Bottle
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Homecare, Specialty Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Validus Pharmaceuticals
- Alvogen
- Micro Labs
- Aurobindo
- Amneal
- County Line Pharmaceuticals
- CorePharma
- Edenbridge Pharmaceuticals
Highlights of The Methenamine Hippurate Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 20 Tablets / Bottle
- 60 Tablets / Bottle
- By Application:
- Hospital
- Homecare
- Specialty Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Methenamine Hippurate Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Methenamine hippurate tablets are a type of medication used to treat asthma. They work by relaxing the airways and helping to reduce inflammation.
Some of the major players in the methenamine hippurate tablets market are Validus Pharmaceuticals, Alvogen, Micro Labs, Aurobindo, Amneal, County Line Pharmaceuticals, CorePharma, Edenbridge Pharmaceuticals.
The methenamine hippurate tablets market is expected to grow at a compound annual growth rate of 3.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Methenamine Hippurate Tablets Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Methenamine Hippurate Tablets Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Methenamine Hippurate Tablets Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Methenamine Hippurate Tablets Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Methenamine Hippurate Tablets Market Size & Forecast, 2020-2028
4.5.1 Methenamine Hippurate Tablets Market Size and Y-o-Y Growth
4.5.2 Methenamine Hippurate Tablets Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 20 Tablets / Bottle
5.2.2 60 Tablets / Bottle
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Homecare
6.2.3 Specialty Clinic
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Methenamine Hippurate Tablets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Methenamine Hippurate Tablets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 20 Tablets / Bottle
9.6.2 60 Tablets / Bottle
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Homecare
9.10.3 Specialty Clinic
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 20 Tablets / Bottle
10.6.2 60 Tablets / Bottle
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Homecare
10.10.3 Specialty Clinic
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 20 Tablets / Bottle
11.6.2 60 Tablets / Bottle
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Homecare
11.10.3 Specialty Clinic
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 20 Tablets / Bottle
12.6.2 60 Tablets / Bottle
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Homecare
12.10.3 Specialty Clinic
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 20 Tablets / Bottle
13.6.2 60 Tablets / Bottle
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Homecare
13.10.3 Specialty Clinic
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Methenamine Hippurate Tablets Market: Competitive Dashboard
14.2 Global Methenamine Hippurate Tablets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Validus Pharmaceuticals
14.3.2 Alvogen
14.3.3 Micro Labs
14.3.4 Aurobindo
14.3.5 Amneal
14.3.6 County Line Pharmaceuticals
14.3.7 CorePharma
14.3.8 Edenbridge Pharmaceuticals
